Search

Your search keyword '"Bleckmann, Annalen"' showing total 420 results

Search Constraints

Start Over You searched for: Author "Bleckmann, Annalen" Remove constraint Author: "Bleckmann, Annalen"
420 results on '"Bleckmann, Annalen"'

Search Results

6. Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

7. Predictors of lower exercise capacity in patients with cancer

9. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution

12. Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2

14. Response of eosinophilic fasciitis associated with Waldenström macroglobulinemia to rituximab

15. BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis

20. Psychoonkologische Versorgung von AYA*

21. Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers.

22. Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315).

24. Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears

25. Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

29. PD‐L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD‐L1‐low and ‐negative patients with non‐small cell lung cancer.

30. Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report

35. Radiomics of Tumor Heterogeneity in 18F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer

36. High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts

37. Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)

39. Liquid Biopsies in Lung Cancer

41. Impact of pre-OP independence in patients with limited brain metastases on long-term survival

42. Additional file 2 of Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution

44. Additional file 1 of Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution

46. Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario

47. Cardiovascular and metabolic determinants of quality of life in patients with cancer

49. Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis

50. Diagnostic red flags: steroid‐treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination

Catalog

Books, media, physical & digital resources